| Literature DB >> 35873989 |
Zhimin Hu1, Li Ren1, Junling Bu1, Xiuyu Liu1,2, Qishuang Li1, Wending Guo1, Ying Ma1, Jian Wang1, Tong Chen1, Ling Wang1, Baolong Jin1, Jinfu Tang1, Guanghong Cui1, Juan Guo1, Luqi Huang1.
Abstract
Salvia miltiorrhiza is one of the most commonly used Chinese medicinal herbs. Tanshinones, the most abundant lipid-soluble bioactive constituents of S. miltiorrhiza, are a class of structural highly oxidized abietane-type diterpenoids with multiple pharmacological activities. Although several enzymes, including diterpene synthase, cytochrome P450, and Fe(II)/2-oxoglutarate-dependent dioxygenase (2OGD), have been functionally characterized in biosynthesis of abietane-type diterpenoids, the highly oxidized structure and complex secondary metabolic network of tanshinones imply that more oxidases should be characterized. Here, we identified a new 2OGD (Sm2OGD25) from S. miltiorrhiza. Molecular cloning and functional studies in vitro showed that Sm2OGD25 could catalyze the hydroxylation of sugiol at C-15 and C-16 positions to produce hypargenin B and crossogumerin C, respectively. The phylogenetic analysis of the DOXC family demonstrated that Sm2OGD25 belongs to the DOXC54 clade. Furthermore, structural modeling and site-directed mutagenesis characterization revealed the importance of the hydrogen-bonding residue Y339 and the hydrophobic residues (V122, F129, A144, A208, F303, and L344) in substrate binding and enzyme activity. This study will promote further studies on the catalytic characterization of plant 2OGDs and the secondary metabolic biosynthesis network of diterpenoids.Entities:
Keywords: Fe(II)/2-oxoglutarate-dependent dioxygenase; Salvia miltiorrhiza; abietane-type diterpenoids; hydroxylation; site-directed mutagenesis
Year: 2022 PMID: 35873989 PMCID: PMC9301305 DOI: 10.3389/fpls.2022.947674
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
FIGURE 1Proposed biopathways of tanshinone-related diterpenoid biosynthesis in Salvia miltiorrhiza. Solid arrows indicate the established relationships, and dashed arrows indicate hypothetical relationships.
FIGURE 2The positions of identified genes on pseudochromosome 6 and scaffolds. (A) Gene location of identified diTPS, CYP450, and 2OGD genes on pseudochromosome 6. (B) The positions of 11 identified genes on scaffolds. Genes in black, blue, and red are functional diTPS, CYP450, and 2OGD genes.
FIGURE 3Functional characterization of recombinant Sm2OGD25. (A) SDS-PAGE of the His-tagged Sm2OGD25 purified by Ni-NTA affinity chromatography. M: protein marker; 1: crude protein of Sm2OGD25; 2: recombinant Sm2OGD25 (purity > 95%) fused with His-tag (predicted M.W.: 43.7 kDa). (B) Enzymatic reaction catalyzed by Sm2OGD25. (C) UPLC-QTOF-MS analysis of 1 and enzymatic product 1a and 1b. (D) (-)-ESI-MS spectra of 1, 1a, and 1b in the negative ion mode. The analysis conditions are described in Supplementary Table 2. Effects of temperature (E) and reaction buffer (F) on enzyme activity of Sm2OGD25.
FIGURE 4Phylogenetic tree analysis of Sm2OGD25 and other DOXCs. The accession numbers of sequences used in this study are shown in Supplementary Table 5. GA, gibberellin; IAA, indole-3-acetic acid; GSL, glucosinolate; SA, salicylic acid; JA, jasmonic acid; DT, diterpenoid; BIA, benzylisoquinoline alkaloid; BX, benzoxazinoid; MIA, monoterpenoid indole alkaloid.
FIGURE 5Predicted structure, structural comparison, and substrate-binding site of Sm2OGD25. (A) 3D structure of Sm2OGD25 predicted by AlphaFold2. (B) Structural alignment of Sm2OGD25 (colored in cyan) and AtJOX2 (PDB ID: 6LSV, colored in slate). The root mean square deviation (RMSD) value is 0.99 Å for 271 Cα atoms. (C) Structure modeling of Sm2OGD25. Sugiol (1) was docked into the potential binding pocket of Sm2OGD25. Residues that were close (< 5 Å) to sugiol (1) are displayed. All protein elements are shown as cartoons or sticks in cyan. Ligands and iron are shown in different colors. The key hydrogen bond interactions are labeled in black dashed lines. The coordination with iron is labeled in yellow dashed lines.
FIGURE 6The relative conversion rates of wild-type (WT) Sm2OGD25 and mutants. In vitro assays of Sm2OGD25 and its variants using sugiol (1) as the substrate. N.D. represents mutants with no detected activity. Error bars indicate standard deviation of three independent replicates.